Management of Heart Failure in Elderly Patients with Impaired Renal Function

Assessment and Pharmacological Management

• The European Society of Cardiology recommends using ACE inhibitors or ARBs in patients with heart failure and renal impairment, with careful dosing and monitoring 1, 5
• The American College of Cardiology suggests that beta-blockers are well-tolerated in elderly patients with heart failure, and should be initiated at low doses with gradual titration 1, 5
• The European Heart Journal states that diuretics are necessary for fluid overload management, but require cautious use in elderly patients with renal impairment, and loop diuretics are preferred over thiazides 1, 8
• The European Society of Cardiology recommends considering mineralocorticoid receptor antagonists (MRAs) in patients with eGFR >30 mL/min/1.73 m² after optimization of ACE inhibitor/ARB and beta-blocker 2, 6

Special Considerations

• The American Heart Association advises avoiding triple RAAS blockade (ACE inhibitor + ARB + MRA) due to increased risk of hyperkalemia 2, 6
• The European Heart Journal recommends careful monitoring for worsening renal function, which could indicate excessive preload reduction or worsening heart failure 1, 7

Monitoring and Follow-up

• The American College of Cardiology suggests regularly monitoring renal function, electrolytes, and fluid status, and adjusting medication doses based on renal function changes 2, 6
• The European Society of Cardiology recommends considering more frequent follow-up visits due to the patient's advanced age and complex condition 8, 9